Physiological regulation of vascular permeability by endogenous glucocorticoids and active oxygen
- 1 March 1983
- journal article
- research article
- Published by Springer Nature in Inflammation
- Vol. 7 (1) , 81-89
- https://doi.org/10.1007/bf00918010
Abstract
A copper chelator, diethyldithiocarbamate (DDC), injection and adrenalectomy induce significant paw swelling by low doses of serotonin, histamine, or bradykinin, which can result in mild swelling in non-treated mice. Dexamethasone, Cu,Zn-superoxide dismutase (SOD), and hydroxyl radical scavengers suppressed the DDC-provoked edema, but only dexamethasone suppressed the edema of adrenalectomized mice. Adrenal stimulation by SOD is exclusive in that the suppression of edema by SOD began about 1 h prior to that by glucocorticoid. In order to explain the data obtained, the existence of a vascular permeability inhibitory protein (called “vasoregulin”) was assumed. This protein must be synthesized constantly somewhere in the body and continuously inactivated by active oxygen in vivo. Local levels of vasoregulin may limit the responses of vascular permeability against the chemical mediators. This hypothesis was also supported by the edema-enhancing effects of protein/RNA synthesis inhibitors.Keywords
This publication has 22 references indexed in Scilit:
- Steroid-like anti-inflammatory effect of superoxide dismutase in serotonin-, histamine- and kinin-induced edemata of mice: Existence of vascular permeability regulating protein(S)Biochemical Pharmacology, 1981
- Mechanism of protection against arachidonate induced sudden death by glucocorticoidProstaglandins, 1981
- Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoidsNature, 1980
- A phospholipase A2 inhibitory protein in rabbit neutrophils induced by glucocorticoids.Proceedings of the National Academy of Sciences, 1980
- The role of glucocorticoid receptor and gene expression in the anti-inflammatory action of dexamethasoneNature, 1979
- Dioxygen and the Vitamin K-Dependent Synthesis of ProthrombinPublished by Wiley ,1979
- Studies on the clinical and laboratory pharmacology of drug formulations of bovine Cu—Zn superoxide dismutases (orgotein)Published by Springer Nature ,1977
- Inhibition of superoxide anion production in macrophages by anti-inflammatory drugsBiochemical Pharmacology, 1976
- Biological protection by superoxide dismutaseBiochemical and Biophysical Research Communications, 1973
- Biological Defense Mechanisms. THE PRODUCTION BY LEUKOCYTES OF SUPEROXIDE, A POTENTIAL BACTERICIDAL AGENTJournal of Clinical Investigation, 1973